Damage Control Surgery Over the World in Acute Diverticulitis (DACOSAD)
Launched by LINK CAMPUS UNIVERSITY · May 20, 2024
Trial Information
Current as of February 12, 2025
Recruiting
Keywords
ClinConnect Summary
The DACOSAD clinical trial is studying a surgical approach called damage control surgery for patients with severe diverticulitis, specifically those with a condition known as Hinchey III or IV. This condition occurs when diverticula, which are small pouches in the intestine, become inflamed and can lead to serious complications like perforation. The trial aims to evaluate whether performing bowel resection (removing part of the intestine), leaving the abdomen open for a while, and then reconnecting the intestine later offers better outcomes for these patients.
To participate in this trial, individuals must be over 18 years old and have undergone surgery for Hinchey III or IV diverticulitis, which involves the specific procedures mentioned. The trial is currently recruiting participants of all genders. Those who join can expect to be monitored closely and contribute to important research that may improve surgical treatments for this serious condition. If you or a loved one is facing this type of surgery, this trial could provide an opportunity to help advance medical knowledge while receiving care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \>18 year-old underwent surgery for Hinchey III and IV and submitted to resection, clip and drop, and open abdomen
- Exclusion Criteria:
- • Subjects \<18 year-old
Trial Officials
Gianluca Costa, Prof.
Study Director
Link Campus University
About Link Campus University
Link Campus University is a distinguished academic institution dedicated to advancing research and education in the fields of health sciences and clinical development. As a clinical trial sponsor, the university leverages its multidisciplinary expertise and innovative methodologies to conduct rigorous research that addresses critical healthcare challenges. Committed to ethical standards and patient safety, Link Campus University fosters collaboration among researchers, healthcare professionals, and industry partners to drive scientific discoveries and improve therapeutic outcomes. Through its robust infrastructure and emphasis on evidence-based practices, the university aims to contribute significantly to the advancement of medical knowledge and the enhancement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, Lazio, Italy
Ostia, Roma, Italy
Palestrina, Roma, Italy
Caserta, , Italy
Roma, , Italy
Roma, , Italy
Pisa, , Italy
Roma, , Italy
Santiago De Chile, , Chile
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0